The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Misconceptions and issues regarding allometric scaling during the drug development process
Abstract
INTRODUCTION: Allometry is the study of size and its consequences. The simple hypothesis of allometric scaling is that all physiological parameters are proportional to body size or body mass. This review examines the development of theory-based allometry or fixed exponents (0.75 and 1.0 for basal metabolic rate and volume, respectively) and the evidence for or against the theory. The main focus of this report is to show the readers that there is enough evidence from experimental data that negate the concept of theory-based allometry in biology, physiology, and pharmacokinetics. Areas covered: In this review, the history of the development of theoretical allometry and the strong evidence against theory-based allometry demonstrated by experimental data is provided. During drug development, allometry is applied to both inter-species (from animals to humans) and intra-species (adults to children) scaling. These two forms of allometric scaling in the context of theory-based allometry are discussed and provide insight on scientific progress that refute theory-based allometry. Expert opinion: Theory-based allometry is a mere theory and experimental data and real-life observations strongly negate the existence of such a theory. Pharmacostatistical and physiological models based on theory-based allometry can be misleading and incorrect because the theory-based allometric exponent 0.75 is not universal. The exponents of allometry are data dependent and are not fixed in the universe.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Third, with only three to four species typically available, the 70 kg prediction intervals are necessarily wider than the point estimates alone would suggest [6,24].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [6]
In the citing paper
“however, the apparent universality of the allometric exponent can obscure compound-specific ADME determinants that differ markedly across species [6,14].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [6]
In the citing paper
“though debate about the precise exponent value continues [5,6].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [6]
In the citing paper
“Volume of distribution, in contrast, scales with an exponent near 1.0, reflecting that the anatomical spaces into which a drug distributes, principally body water and tissue mass, increase in approximately direct proportion to body size;”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [6]
In the citing paper
“Allometry provides a first approximation, but ADME processes are fundamentally pathway- and species-dependent, and a visually compelling log–log line across a narrow species panel may still catastrophically mispredict human pharmacokinetics [6,14,21].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [6]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A General Model for the Origin of Allometric Scaling Laws in Biology
West, G. B., Brown, J. H., & Enquist, B. J. (1997) · Science · doi:10.1126/science.276.5309.122 · Cited by 5,016
Scaling: Why is Animal Size so Important?
Schmidt-Nielsen, K. (1984) · doi:10.1017/cbo9781139167826 · Cited by 2,677
ALLOMETRY AND SIZE IN ONTOGENY AND PHYLOGENY
GOULD, S. J. (1966) · Biological Reviews · doi:10.1111/j.1469-185x.1966.tb01624.x · Cited by 2,280
Kleiber, M. (1932) · Hilgardia · doi:10.3733/hilg.v06n11p315 · Cited by 2,222
Kleiber, M. (1947) · Physiological Reviews · doi:10.1152/physrev.1947.27.4.511 · Cited by 1,817
The Fourth Dimension of Life: Fractal Geometry and Allometric Scaling of Organisms
West, G. B., Brown, J. H., & Enquist, B. J. (1999) · Science · doi:10.1126/science.284.5420.1677 · Cited by 1,718 · cited 2×
“[17,18] initiated a serious debate about the nature of allometric exponents.”
BackgroundApplied Biopharmaceutics and Pharmacokinetics.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-6-826_2 · Cited by 1,206
Glazier, D. S. (2005) · Biological Reviews · doi:10.1017/s1464793105006834 · Cited by 1,069
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Scaling of respiratory variables in mammals
Stahl, W. R. (1967) · Journal of Applied Physiology · doi:10.1152/jappl.1967.22.3.453 · Cited by 853
Research works printed but not linked: 16
- Huxley JS, 1936, Comptes Rendus Se´Ances Soc. Biol. Fil., 121, 934
- Mcmohan TA, 1983, On size and life., 25
- Brody S, 1934, Univ Missouri Agric Exp Sta Res Bull, 220, 1
- Author reply, Science, 278, 372
- Heusner AA, 1982, Is the 0.75 Mass Exponent of Kleiber’s Equation a Statistical Artifact? Resp Physiol, 48, 13
- Ritschel WA, 1986, Meth and Find Exptl Clin Pharmacol, 8, 603
- Mahmood I, Interspecies Pharmacokinetic scaling: principles and application of allometric scaling, 2005
- Dedrick RL, 1970, Cancer Chemother Rep, 54, 95
- Boxenbaum H, 1983, Am J Physiol, 245, R768
- Mahmood I, Interspecies Pharmacokinetic scaling: principles and application of allometric scaling, 2005
- Mahmood I, 2005, Interspecies Pharmacokinetic scaling. principles and application of allometric scaling, 188
- Mahmood I, 2005, Interspecies Pharmacokinetic scaling. Principles and application of allometric scaling, 206
- Mahmood I, 2013, Pharmacokinetic allometric scaling in pediatric drug development, 88
- Mahmood I, 2013, Pharmacokinetic allometric scaling in pediatric drug development, 101
- Mahmood I, 2013, Am J Ther, 20, 21
- Pathirana S, J Clin Pharmacol
Cited by
Variable metabolic scaling breaks the law: from ‘Newtonian’ to ‘Darwinian’ approaches
Glazier, D. S. (2022) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.1605 · Cited by 102
Clinical Pharmacology of Antibody-Drug Conjugates
Mahmood, I. (2021) · Antibodies · doi:10.3390/antib10020020 · Cited by 75
Self-citationvan Valkengoed, D. W., Krekels, E. H. J., & Knibbe, C. A. J. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01444-6 · Cited by 55
Interactive effects of intrinsic and extrinsic factors on metabolic rate
Glazier, D. S., & Gjoni, V. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0489 · Cited by 47
van Rongen, A., Krekels, E. H. J., Calvier, E. A. M., de Wildt, S. N., Vermeulen, A., & Knibbe, C. A. J. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.2027907 · Cited by 35
Metadata
- Authors
- Mahmood, I.
- Affiliations
- Center for Biologics Evaluation and Research (US)
- Corresponding author
- Mahmood, Iftekhar
- ORCID
- Mahmood, Iftekhar
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2018-07-19
- Volume
- 14
- Issue
- 8
- Pages
- 843-854
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2883244306
- Cited by
- 35
- References
- 102
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 10 · 2021: 5 · 2020: 5 · 2019: 1
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Physical Sciences › Environmental Science › Ecology › Physiological and biochemical adaptations
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- allometric scaling, allometric exponent, basal metabolic rate, body mass scaling, pediatric dosing, pharmacokinetics
- MeSH terms
- Adult, Age Factors, Animals, Child, Pharmaceutical Preparations, Humans, Models, Theoretical, Pharmacokinetics, Species Specificity, Drug Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Misconceptions and issues regarding allometric scaling during the drug development process. https://app.cochat.ai/papers/10.1080/17425255.2018.1499725
- The paper
- Mahmood, I. (2018). Misconceptions and issues regarding allometric scaling during the drug development process. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2018.1499725
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.